Exchange: NASDAQ·Updated 06:51 PM EDT
ATRA logo

ATRA Atara Biotherapeutics Inc

$10.34
$0.23
(2.41%)
Today
Closed $9.76
$0.58
(5.94%)
After Hours
Reported EarningsAug 12
Mkt Cap$95.66M
Vol135,276.00

About ATRA

Atara Biotherapeutics, Inc. is an allogeneic T-cell immunotherapy company, which engages in the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases. It also delivers off-the-shelf treatments to patients with high unmet medical need. Its product pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in Thousand Oaks, CA.
59

Bullish Sentiment

How do you feel about ATRA?

Advertisement|Remove ads.